Adjuvant treatment of high-risk primary uterine Ieiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D): Results of phase II multicenter trial SARC005 Meeting Abstract
| Authors: | Hensley, M. L.; Wathen, K.; Maki, R. G.; Araujo, D. M.; Sutton, G.; Priebat, D. A.; George, S.; Baker, L. H. |
| Abstract Title: | Adjuvant treatment of high-risk primary uterine Ieiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D): Results of phase II multicenter trial SARC005 |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-01 |
| Start Page: | 703s |
| Language: | English |
| ACCESSION: | WOS:000208852005530 |
| DOI: | 10.1200/jco.2010.28.15_suppl.10021 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10021 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
